miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 17, Pages 2673
Publisher
MDPI AG
Online
2022-08-29
DOI
10.3390/cells11172673
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
- (2022) Fahong Li et al. Emerging Microbes & Infections
- MicroRNA-200c Attenuates the Tumor-Infiltrating Capacity of Macrophages
- (2022) Rebecca Raue et al. Biology-Basel
- Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
- (2022) Shangshang Hu et al. PLoS One
- High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
- (2022) Zhitao Chen et al. Genes
- Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
- (2022) Tongyu Meng et al. Frontiers in Genetics
- Exosomal miR‐512‐3p derived from mesenchymal stem cells inhibits oxidized low‐density lipoprotein‐induced vascular endothelial cells dysfunction via regulating Keap1
- (2021) Sisi Chen et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
- (2021) Zuxiong Tang et al. PeerJ
- Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
- (2021) Pablo Fernández-Tussy et al. Cell Death & Disease
- Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma
- (2021) Ho-Yeop Lee et al. Cells
- Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
- (2021) Michele Manganelli et al. Biomedicines
- miR ‐222‐5p promotes dysfunction of human vascular smooth muscle cells by targeting RB1
- (2021) Yihang Liu et al. ENVIRONMENTAL TOXICOLOGY
- CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway
- (2021) Yan-ming Liu et al. International Journal of Biological Sciences
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness
- (2021) Seongki Min et al. Cell Death & Disease
- ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
- (2021) Honglei Cui et al. Frontiers in Cell and Developmental Biology
- LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge
- (2021) Zhixiang Qin et al. Cell Death Discovery
- Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
- (2021) Yuchen Liu et al. JOURNAL OF HEPATOLOGY
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
- (2020) Laura Gramantieri et al. CANCER RESEARCH
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Proto-Oncogene Serine/Threonine Kinase PIM3 Promotes Cell Migration via Modulating Rho GTPase Signaling
- (2020) Yamei Dang et al. JOURNAL OF PROTEOME RESEARCH
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma
- (2020) Shuo Wang et al. OncoTargets and Therapy
- Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
- (2020) Federico Piñero et al. Cells
- Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
- (2020) Qiuyue Hu et al. DISEASE MARKERS
- Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
- (2020) Tomoki Kohno et al. Oncology Letters
- Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer
- (2020) Raúl González et al. Redox Biology
- Exosomal miR-200c-3p negatively regulates the migration and invasion of lipopolysaccharide (LPS)-stimulated colorectal cancer (CRC)
- (2020) Yimei Jiang et al. BMC Molecular and Cell Biology
- Liquid biopsy in the clinical management of hepatocellular carcinoma
- (2020) Johann von Felden et al. GUT
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- Extracellular vesicles transmitted miR‐31‐5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma
- (2019) Jinlan He et al. INTERNATIONAL JOURNAL OF CANCER
- Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles
- (2019) Mostafa Kiamehr et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
- (2019) Peter R. Galle et al. LIVER INTERNATIONAL
- A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development
- (2018) Pia Sulas et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA 200c-3p regulates autophagy via upregulation of endoplasmic reticulum stress in PC-3 cells
- (2018) Eun Jung Sohn Cancer Cell International
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells
- (2018) María A. Rodríguez-Hernández et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
- (2017) Qie Guo et al. Oncotarget
- The role of autophagy in hepatocellular carcinoma: friend or foe
- (2017) Lian Liu et al. Oncotarget
- Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis
- (2016) Xiaofang Sun et al. HEPATOLOGY
- Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
- (2016) Zhen Qu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes
- (2016) Regina Krattinger et al. LIFE SCIENCES
- Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy
- (2016) M Gugnoni et al. ONCOGENE
- SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis
- (2016) Jianni Qi et al. FEBS Open Bio
- Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma
- (2015) Xiang Qi et al. Oncotarget
- miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
- (2014) KAI LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
- (2012) Wen Wang et al. CARCINOGENESIS
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
- (2011) X-X He et al. ONCOGENE
- MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
- (2010) Q. W-L. Wong et al. CLINICAL CANCER RESEARCH
- Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver
- (2010) Y Wu et al. ONCOGENE
- Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
- (2009) Zhe Zhang et al. BMC Medicine
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Hep G2 is a hepatoblastoma-derived cell line
- (2009) Dolores López-Terrada et al. HUMAN PATHOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
- (2009) C Coulouarn et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search